Company · CIK 1822929
Eucrates Biomedical Acquisition Corp.
| CIK | 1822929 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 6770 — Blank Checks |
| Incorporated in | D8 |
| Business address | NY |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-12-07 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-249333 | 2020-10-06 | 2020-10-26 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2020-10-26 | 424B4Final prospectus | 333-249333 | 0001104659-20-118165 |
| 2020-10-23 | EFFECTDeclared effective | 333-249333 | 9999999995-20-002965 |
| 2020-10-21 | S-1/AAmendment | 333-249333 | 0001104659-20-116715 |
| 2020-10-15 | S-1/AAmendment | 333-249333 | 0001104659-20-115329 |
| 2020-10-06 | S-1Registration filed | 333-249333 | 0001104659-20-112311 |
| 2020-09-02 | DRSDraft made public | 377-03487 | 0001104659-20-101557 |